Jul 17, 2019 7:00 am EDT Capricor Therapeutics and Parents Project Muscular Dystrophy to Host Webinar to Discuss Interim Analysis of the HOPE-2 Clinical Trial to Treat Patients with Duchenne Muscular Dystrophy
Jul 15, 2019 6:00 am EDT Capricor Therapeutics Announces Positive Results from its Interim Analysis in the HOPE-2 Trial to Treat Patients with Duchenne Muscular Dystrophy
May 13, 2019 4:00 pm EDT Capricor Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update
May 06, 2019 4:00 pm EDT Capricor Therapeutics to Present First Quarter 2019Â Financial Results and Recent Corporate Update on May 13
Mar 28, 2019 4:00 pm EDT Capricor Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
Mar 21, 2019 8:00 am EDT Capricor Therapeutics to Present Fourth Quarter and Full Year 2018 Financial Results and Recent Corporate Update on March 28
Feb 06, 2019 7:00 am EST Capricor Resumes Dosing of Enrolled Patients in HOPE-2 Clinical Trial for Duchenne Muscular Dystrophy
Jan 24, 2019 7:00 am EST Neurology Publishes Study Reporting Significant Improvements in Duchenne Muscular Dystrophy Patients Treated with Capricor’s Novel Cell Therapy
Jan 22, 2019 7:00 am EST Capricor Announces Positive Outcomes from Comprehensive Multidisciplinary Meeting with FDA
Nov 13, 2018 4:01 pm EST Capricor Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update